BRIDGEWAY CAPITAL MANAGEMENT, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2021$366,000
-7.1%
200,0000.0%0.01%0.0%
Q1 2021$394,000
+282.5%
200,000
+1251.4%
0.01%
+600.0%
Q1 2019$103,000
+19.8%
14,8000.0%0.00%0.0%
Q4 2018$86,000
-91.9%
14,800
-89.5%
0.00%
-90.0%
Q3 2018$1,062,000140,7150.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders